Is Open Science Better Science?
Ewout W. Steyerberg, PhD
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands
Abstract
The Open Science movement has many components, including Open Access to scientific publications, sharing of research data, and providing open source software. These components are expected to contribute to better science. In this seminar I aim to reflect on the strength and limitations of Open Science in the context of epidemiological research.
First, I note that by making research more open, the scale of research increases; this might enable addressing some research questions better. This allows us to recognize that different researchers use different scientific approaches; Open science makes that we become increasingly aware of different styles in research.
Second, we may hope to learn more about the value of modern approaches to data analysis such as machine learning. Indeed, neutral comparison studies benefit from the open availability of multiple data sets that can be analyzed with standardized approaches to the analysis, adding realism compared to analytical and simulation studies.
Third, I note that more data sharing is a positive development, especially to highlight heterogeneity between settings. In sum, I remain optimistic that open science will lead to better science, with the caveat that we recognize complexities that limit the interpretation of increasing amounts of data, such as the medical context, study design, measurement and data analysis.
These slides were presented in a series of lectures organized by Prof Marianna Huebner, June 2, 2022
Presentation on similarities and differences between statistical and machine learning research fields for the @UM_MiCHAMP Big Data & AI in Health Seminar Series; October 21, 2022
The fourth paradigm: data intensive scientific discovery - Jisc Digifest 2016Jisc
There is broad recognition within the scientific community that the emerging data deluge will fundamentally alter disciplines in areas throughout academic research. A wide variety of researchers - from scientists and engineers to social scientists and humanities researchers - will require tools, technologies, and platforms that seamlessly integrate into standard scientific methodologies and processes.
'The fourth paradigm' refers to the data management techniques and the computational systems needed to manipulate, visualize, and manage large amounts of research data. This talk will illustrate the challenges researchers will face, the opportunities these changes will afford, and the resulting implications for data-intensive researchers.
In addition, the talk will review the global movement towards open access, research repositories and open science and the importance of curation of digital data. The talk concludes with some comments on the research requirements for campus e-infrastructure and the end-to-end performance of the network.
Presentation on similarities and differences between statistical and machine learning research fields for the @UM_MiCHAMP Big Data & AI in Health Seminar Series; October 21, 2022
The fourth paradigm: data intensive scientific discovery - Jisc Digifest 2016Jisc
There is broad recognition within the scientific community that the emerging data deluge will fundamentally alter disciplines in areas throughout academic research. A wide variety of researchers - from scientists and engineers to social scientists and humanities researchers - will require tools, technologies, and platforms that seamlessly integrate into standard scientific methodologies and processes.
'The fourth paradigm' refers to the data management techniques and the computational systems needed to manipulate, visualize, and manage large amounts of research data. This talk will illustrate the challenges researchers will face, the opportunities these changes will afford, and the resulting implications for data-intensive researchers.
In addition, the talk will review the global movement towards open access, research repositories and open science and the importance of curation of digital data. The talk concludes with some comments on the research requirements for campus e-infrastructure and the end-to-end performance of the network.
Panel: Our Scholarly Recognition System Doesn’t Still WorkDaniel S. Katz
A panel at the 2015 Science of Team Science (SciTS) Conference
Organizers: Daniel S. Katz (U. of Chicago & Argonne National Laboratory), Amy Brand (Digital Science), Melissa Haendel (Oregon Health & Science University), Holly J. Falk-Krzesinski (Elsevier)
Panelists: Robin Champieux (Oregon Health & Science University) Holly Falk-Krzesinski (Elsevier)Daniel S. Katz (U. of Chicago & Argonne National Laboratory)Philippa Saunders (University of Edinburgh)
Abstract: http://bit.ly/scholarly-recognition
Clinical trial data wants to be free: Lessons from the ImmPort Immunology Dat...Barry Smith
Presentation to the Clinical and Research Ethics Seminar, Clinical and Translational Science Center, Buffalo, January 21, 2014
https://immport.niaid.nih.gov/
http://youtu.be/booqxkpvJMg
Graphs and Artificial Intelligence have long been a focus for Franz Inc. and currently we are collaborating with Montefiore Health System, Intel, Cloudera, and Cisco to improve a patient’s ability to understand the probabilities of their future health status. By combining artificial intelligence, semantic technologies, big data, graph databases and dynamic visualizations we are deploying a Cognitive Probability Graph concept as a means to help predict future medical events.
The power of Cognitive Probability Graphs stems from the capability to combine the probability space (statistical patient data) with a knowledge base of comprehensive medical codes and a unified terminology system. Cognitive Probability Graphs are remarkable not just because of the possibilities they engender, but also because of their practicality. The confluence of machine learning, semantics, visual querying, graph databases, and big data not only displays links between objects, but also quantifies the probability of their occurrence.
We believe this approach will be transformative for the healthcare field and we see numerous possibilities that exist across business verticals.
During the presentation we will describe the Cognitive Probability Graph concepts using a distributed graph database on top of Hadoop along with the query language SPARQL to extract feature vectors out of the data, applying R and SPARK ML, and then returning the results for further graph processing. #AllegroGraph
From Text to Data to the World: The Future of Knowledge GraphsPaul Groth
Keynote Integrative Bioinformatics 2018
https://docs.google.com/document/d/1E7D4_CS0vlldEcEuknXjEnSBZSZCJvbI5w1FdFh-gG4/edit
Can we improve research productivity through providing answers stemming from knowledge graphs? In this presentation, I discuss different ways of building and combining knowledge graphs.
What is the reproducibility crisis in science and what can we do about it?Dorothy Bishop
Talk given to the Rhodes Biomedical Association, 4th May 2016.
For references see: http://www.slideshare.net/deevybishop/references-on-reproducibility-crisis-in-science-by-dvm-bishop
Sharing and standards christopher hart - clinical innovation and partnering...Christopher Hart
Acknowledging the increasing need for cooperation and collaboration in data sharing and access. Describing the complexity that this can bring. Then describing some of the ways to simplify that.
Originally presented at Terrapin's Clinical innovation and partnering world March 8-9 2017.
http://www.terrapinn.com/conference/innovation-and-partnering/index.stm
The Uneven Future of Evidence-Based MedicineIda Sim
An Apple ResearchKit study enrolled 22,000 people in five days. A
study claims that Twitter can be used to identify depressed patients. A computer program crunches genomic data, the published literature, and electronic health record data to guide cancer treatment. The pace, the data sources, and the methods for generating medical evidence are changing radically. What will — what should — evidence-based medicine look like in a faster, personalized, data-dense tomorrow?
- Presented as the 3rd Annual Cochrane Lecture, October 2015 in Vienna, Austria.
ISMB/ECCB 2013 Keynote Goble Results may vary: what is reproducible? why do o...Carole Goble
Keynote given by Carole Goble on 23rd July 2013 at ISMB/ECCB 2013
http://www.iscb.org/ismbeccb2013
How could we evaluate research and researchers? Reproducibility underpins the scientific method: at least in principle if not practice. The willing exchange of results and the transparent conduct of research can only be expected up to a point in a competitive environment. Contributions to science are acknowledged, but not if the credit is for data curation or software. From a bioinformatics view point, how far could our results be reproducible before the pain is just too high? Is open science a dangerous, utopian vision or a legitimate, feasible expectation? How do we move bioinformatics from one where results are post-hoc "made reproducible", to pre-hoc "born reproducible"? And why, in our computational information age, do we communicate results through fragmented, fixed documents rather than cohesive, versioned releases? I will explore these questions drawing on 20 years of experience in both the development of technical infrastructure for Life Science and the social infrastructure in which Life Science operates.
A critical reflection on the role of Machine Learning in medical research, with specific comparisons to more classical statistical approaches to learning from data
A short introduction to some problems in science, with a focus on reproducibility in medical research, including some examples from COVID research, and some hints for improvement in the research process
More Related Content
Similar to Open Science Better Science? Steyerberg 2June2022.pptx
Panel: Our Scholarly Recognition System Doesn’t Still WorkDaniel S. Katz
A panel at the 2015 Science of Team Science (SciTS) Conference
Organizers: Daniel S. Katz (U. of Chicago & Argonne National Laboratory), Amy Brand (Digital Science), Melissa Haendel (Oregon Health & Science University), Holly J. Falk-Krzesinski (Elsevier)
Panelists: Robin Champieux (Oregon Health & Science University) Holly Falk-Krzesinski (Elsevier)Daniel S. Katz (U. of Chicago & Argonne National Laboratory)Philippa Saunders (University of Edinburgh)
Abstract: http://bit.ly/scholarly-recognition
Clinical trial data wants to be free: Lessons from the ImmPort Immunology Dat...Barry Smith
Presentation to the Clinical and Research Ethics Seminar, Clinical and Translational Science Center, Buffalo, January 21, 2014
https://immport.niaid.nih.gov/
http://youtu.be/booqxkpvJMg
Graphs and Artificial Intelligence have long been a focus for Franz Inc. and currently we are collaborating with Montefiore Health System, Intel, Cloudera, and Cisco to improve a patient’s ability to understand the probabilities of their future health status. By combining artificial intelligence, semantic technologies, big data, graph databases and dynamic visualizations we are deploying a Cognitive Probability Graph concept as a means to help predict future medical events.
The power of Cognitive Probability Graphs stems from the capability to combine the probability space (statistical patient data) with a knowledge base of comprehensive medical codes and a unified terminology system. Cognitive Probability Graphs are remarkable not just because of the possibilities they engender, but also because of their practicality. The confluence of machine learning, semantics, visual querying, graph databases, and big data not only displays links between objects, but also quantifies the probability of their occurrence.
We believe this approach will be transformative for the healthcare field and we see numerous possibilities that exist across business verticals.
During the presentation we will describe the Cognitive Probability Graph concepts using a distributed graph database on top of Hadoop along with the query language SPARQL to extract feature vectors out of the data, applying R and SPARK ML, and then returning the results for further graph processing. #AllegroGraph
From Text to Data to the World: The Future of Knowledge GraphsPaul Groth
Keynote Integrative Bioinformatics 2018
https://docs.google.com/document/d/1E7D4_CS0vlldEcEuknXjEnSBZSZCJvbI5w1FdFh-gG4/edit
Can we improve research productivity through providing answers stemming from knowledge graphs? In this presentation, I discuss different ways of building and combining knowledge graphs.
What is the reproducibility crisis in science and what can we do about it?Dorothy Bishop
Talk given to the Rhodes Biomedical Association, 4th May 2016.
For references see: http://www.slideshare.net/deevybishop/references-on-reproducibility-crisis-in-science-by-dvm-bishop
Sharing and standards christopher hart - clinical innovation and partnering...Christopher Hart
Acknowledging the increasing need for cooperation and collaboration in data sharing and access. Describing the complexity that this can bring. Then describing some of the ways to simplify that.
Originally presented at Terrapin's Clinical innovation and partnering world March 8-9 2017.
http://www.terrapinn.com/conference/innovation-and-partnering/index.stm
The Uneven Future of Evidence-Based MedicineIda Sim
An Apple ResearchKit study enrolled 22,000 people in five days. A
study claims that Twitter can be used to identify depressed patients. A computer program crunches genomic data, the published literature, and electronic health record data to guide cancer treatment. The pace, the data sources, and the methods for generating medical evidence are changing radically. What will — what should — evidence-based medicine look like in a faster, personalized, data-dense tomorrow?
- Presented as the 3rd Annual Cochrane Lecture, October 2015 in Vienna, Austria.
ISMB/ECCB 2013 Keynote Goble Results may vary: what is reproducible? why do o...Carole Goble
Keynote given by Carole Goble on 23rd July 2013 at ISMB/ECCB 2013
http://www.iscb.org/ismbeccb2013
How could we evaluate research and researchers? Reproducibility underpins the scientific method: at least in principle if not practice. The willing exchange of results and the transparent conduct of research can only be expected up to a point in a competitive environment. Contributions to science are acknowledged, but not if the credit is for data curation or software. From a bioinformatics view point, how far could our results be reproducible before the pain is just too high? Is open science a dangerous, utopian vision or a legitimate, feasible expectation? How do we move bioinformatics from one where results are post-hoc "made reproducible", to pre-hoc "born reproducible"? And why, in our computational information age, do we communicate results through fragmented, fixed documents rather than cohesive, versioned releases? I will explore these questions drawing on 20 years of experience in both the development of technical infrastructure for Life Science and the social infrastructure in which Life Science operates.
A critical reflection on the role of Machine Learning in medical research, with specific comparisons to more classical statistical approaches to learning from data
A short introduction to some problems in science, with a focus on reproducibility in medical research, including some examples from COVID research, and some hints for improvement in the research process
Symposium Data-driven risk-based decisions; PhD defense Tom Hueting
Wednesday 22 juni 2022
Universiteit Twente
I present some issues on improving prediction models by updating and adding markers
Prediction research: perspectives on performance Stanford 19May22.pptxEwout Steyerberg
A presentation on prediction modeling research, assessment of performance and possibilities for improving performance. I discuss statistical performance measures (discrimination; calibration), and decision-analytic performance measures (Net Benefit).
Improvement may come from continuous updating strategies ('a learning health system'?), strong biomarkers (e.g. blood values; omics; imaging), and less so from new methods (AI / Machine learning) than some might hope.
Presented for Stanford, BMIR colloquium, May 19, 2022
Prediction, Big Data, and AI: Steyerberg, Basel Nov 1, 2019Ewout Steyerberg
Title"Clinical prediction models in the age of artificial intelligence and big data", presented at the Basel Biometrics Society seminar Nov 1, 2019, Basel, by Ewout Steyerberg, with substantial inout from Maarten van Smeden and Ben van Calster
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Nutraceutical market, scope and growth: Herbal drug technology
Open Science Better Science? Steyerberg 2June2022.pptx
1. June, 2022
Is Open Science Better Science?
Ewout W. Steyerberg, PhD
Professor of Clinical Biostatistics and
Medical Decision Making
Thanks to many for assistance and inspiration,
including the GAP3 consortium, CENTER-TBI Study
Yes, but …
2. Open vs closed science
Long ago
- Performed by few, elitarian scientists
- Doing private experiments
- Discussion in small, closed communities
3. Probabilities to quantify uncertainty
• Christiaan Huygens 1657:
'Van rekeningh in spelen van geluck'
• Thomas Bayes 1763:
An Essay towards solving a Problem in the Doctrine of Chances”
(read to the Royal Society by Richard Price)
• Pierre Laplace 1812:
Théorie analytique des probabilités
6-Jun-22
3 Insert > Header & footer
4. Open vs closed science
Long ago
- Performed by few, elitarian scientists
- Doing private experiments
- Discussion in small, closed communities
Recent
- Science as a profession
- Protect data + code as intellectual property
- Aim for shocking findings in high IF journals
https://www.sciencemag.org/news/2020/06/whos-blame-these-three-scientists-are-heart-surgisphere-covid-19-scandal
5. Overall claim
“Open Science will make research better”
Vote pro / neutral / con
“More data is better”
Vote pro / neutral / con
6-Jun-22
5 Insert > Header & footer
6. Today
Aims:
- Highlight some strong points in Open Science
- Hint at some challenges in Open Science
Reflections based on personal 30-yr research experience,
specific focus on prediction research / decision making
6-Jun-22
6 Insert > Header & footer
8. Open science research questions: case 1
Example 1: Red cards and dark skin soccer players
https://psyarxiv.com/qkwst/
6-Jun-22
8 Insert > Header & footer
9. Open science research questions: case 1
• 29 teams involving 61 analysts; same dataset; same research question:
whether soccer referees are more likely to give red cards to dark skin
toned players than light skin toned players
• Estimated odds ratios 0.89 –2.93 (median 1.3)
• 20 teams: statistically significant positive effect, 9: non-significant relation
6-Jun-22
9 Insert > Header & footer
12. Open science research questions: case 1
• 29 teams involving 61 analysts; same dataset; same research question:
whether soccer referees are more likely to give red cards to dark skin toned
players than light skin toned players
• Estimated odds ratios 0.89 –2.93 (median 1.3).
• 20 teams: statistically significant positive effect, 9: non-significant relation.
• 21 unique combinations of covariates
• “Variation in analysis of complex data may be difficult to
avoid, even by experts with honest intentions”
6-Jun-22
12 Insert > Header & footer
13. Open science research questions: case 2
6-Jun-22
13 Insert > Header & footer
Example from Maarten van Smeden
@MaartenvSmeden
15. Findings not convincing
Cox, #4, 30 vars, max c =0.793
RF, #7, 600 vars, c=0.797
Elastic, #9, 600 vars, c=0.801
6-Jun-22
15 Insert > Header & footer
16. Machine learning vs conventional modeling
1. Findings convincing?
“We found that random forests did not outperform Cox models despite their
inherent ability to accommodate nonlinearities and interactions. …
Elastic nets achieved the highest discrimination performance …, demonstrating
the ability of regularisation to select relevant variables and optimise model
coefficients in an EHR context.”
6-Jun-22
16 Insert > Header & footer
17. Machine learning vs conventional modeling
1. Findings convincing? Not in case-study
2. Systematic / ”it depends” ?
6-Jun-22
17 Insert > Header & footer
20. Open science research questions: case 2
• 243 real datasets from “the OpenML database”
• RF performed better than LR:
mean difference between RF and LR was 0.041 (95%-CI =[0.031,0.053]) for
the Area Under the ROC Curve
• Results were dependent on the inclusion criteria used to select the example
datasets
• ES: Results rely on 10 x 10-fold cross-validation
6-Jun-22
20 Insert > Header & footer
21. Open science research questions: case 2
• More clarification needed when ML / RF works best; at least large N needed
6-Jun-22
21 Insert > Header & footer
22. Systematic review on ML vs classic modeling
6-Jun-22
22 Insert > Header & footer
25. Summary on examples of Open Science
to better address Big research questions
• 1 data set
• multiple modelers
• Multiple modeling options
• 1 neutral comparison; 243 OpenML databases
• Review of 282 comparative studies: meta-research
6-Jun-22
25 Insert > Header & footer
38. Open Science challenge:
dealing with heterogeneity for prediction research
Heterogeneity
• Study design
• Selection of subjects
• Measurement of covariates
• Measurement of outcomes
• Associations of covariates with outcome
• Overall outcome rates
• Performance of prediction models